KCAS Bio will be attending SITC on November 4th – 8th in Phoenix, AZ.
SITC convenes researchers, clinicians, and biopharmaceutical developers to explore the latest breakthroughs in immune-based cancer treatments. These field experts will discuss cutting-edge research and clinical needs within immuno-oncology, such as new checkpoint inhibitors, cancer vaccines, cell and gene therapies, and more. With an agenda of speaker sessions and exhibits, SITC fosters meaningful collaboration across disciplines.
Immunotherapy at KCAS Bio
KCAS Bio has extensive experience in immunology, oncology, and regulatory science that allows us to support the unique demands of any immuno-oncology study.
KCAS Bio is committed to advancing the future of cancer research by remaining actively engaged in the evolving landscape of immuno-oncology. Through ongoing participation in leading scientific conferences and collaboration with industry innovators, we continuously refine our approaches, integrate new technologies, and adapt our strategies to meet the needs of tomorrow’s therapies.
Come See Us
If you’ll be attending SITC, please reach out to our team to discuss your projects.